{"": [146, 149, 0, 150, 195, 0, 196, 1067, 0, 1078, 2884, 0], "INTRODUCTION": [2885, 7638, 0], "Study design and timeline": [7648, 9587, 0], "The RBD + 3M-052-alum vaccine induces robust humoral immunity in RMs": [9588, 13547, 0], "The RBD + 3M-052-alum vaccine induces strong and durable RBD-specific CD8+ and TH1-biased CD4+ T cell responses in the blood": [13548, 15088, 0], "The RBD + 3M-052-alum vaccine significantly reduces viral load in LRT and URT after SARS-CoV-2 challenge": [15089, 19281, 0], "The RBD + 3M-052-alum vaccine reduces lung pathology after respiratory challenge with SARS-CoV-2": [19282, 20287, 0], "Immune correlates of protection upon SARS-CoV-2 challenge in RMs": [20288, 21654, 0], "The RBD + 3M-052-alum vaccine reduces expansion of intermediate blood monocytes after SARS-CoV-2 challenge": [21655, 25902, 0], "RBD + 3M-052-alum vaccine\u2013induced plasma cells accumulate in draining lymph nodes and not in the BM": [25903, 28013, 0], "The RBD + 3M-052-alum vaccine induces higher expression of tissue homing chemokine markers on vaccine enriched blood ASCs": [28014, 30793, 0], "RESULTS": [7639, 30793, 1], "DISCUSSION": [30794, 40778, 0], "Study design": [40802, 41621, 0], "Cloning and expression of SARS-CoV-2 RBD in the yeast P. pastoris": [41622, 41985, 0], "Adjuvants and formulations": [41986, 42574, 0], "Animals": [42575, 43150, 0], "Immunization details": [43151, 43812, 0], "Analyses of anti-RBD IgG binding Ab responses": [43813, 44384, 0], "Multiplexed analyses of anti-RBD, spike, and nucleocapsid Ab responses": [44385, 45168, 0], "Pseudovirus neutralizing assay": [45169, 48236, 0], "Live SARS-CoV-2 neutralizing or focus reduction neutralization titer assay": [48237, 48971, 0], "ELISA for anti-RBD IgG subclasses": [48972, 49838, 0], "ELISA for anti-RBD IgG in secretions": [49839, 50920, 0], "ELISA for total IgG in secretions": [50921, 51296, 0], "Ab-dependent phagocytosis": [51297, 52302, 0], "Spike protein\u2013expressing cell Ab binding assay": [52303, 52770, 0], "Ab-dependent NK cell degranulation assay": [52771, 53315, 0], "T cell stimulation and intracellular cytokine staining assays": [53316, 54371, 0], "PBMC staining for flow cytometry after challenge": [54372, 54511, 0], "MSD cytokine assay": [54512, 54786, 0], "ELISpot assays to quantify ASCs in blood, LN, and BM": [54787, 54958, 0], "Viral stock": [54959, 55309, 0], "SARS-CoV-2 infection": [55310, 55709, 0], "Sampling of virus in nasal, throat, and BAL": [55710, 56784, 0], "Quantifying VL RNA": [56785, 57122, 0], "Histopathology": [57123, 57503, 0], "Statistics": [57504, 58813, 0], "MATERIALS AND METHODS": [40779, 58813, 1], "Supplementary Material": [58814, 58876, 0]}